SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-12-085680
Filing Date
2012-12-21
Accepted
2012-12-21 08:00:41
Documents
6
Period of Report
2012-12-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a12-29895_18k.htm 8-K 28950
2 EX-10.1 a12-29895_1ex10d1.htm EX-10.1 94814
3 EX-10.2 a12-29895_1ex10d2.htm EX-10.2 88963
4 EX-10.3 a12-29895_1ex10d3.htm EX-10.3 88590
5 EX-10.4 a12-29895_1ex10d4.htm EX-10.4 94850
6 EX-10.5 a12-29895_1ex10d5.htm EX-10.5 94564
  Complete submission text file 0001104659-12-085680.txt   492128
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 121279106
SIC: 2835 In Vitro & In Vivo Diagnostic Substances